Jeddah, Saudi Arabia

Eslam M Taha

This inventor holds 1 USPTO granted patent. Top assignee: King Abdulaziz University. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eslam M Taha. Retrieved from https://idiyas.com/inventor/eslam-m-taha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eslam M Taha: Innovator in Actinium-225 Production

Introduction

Eslam M Taha is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of nuclear science, particularly in the production of Actinium-225. His innovative work has implications for various applications, including medical treatments.

Latest Patents

Eslam M Taha holds a patent for "Systems and methods for producing Actinium-225." This patent describes an Actinium-225 generator that includes a neutron source and a neutron target made of nickel. Additionally, it features a proton target that utilizes radium-226. The methods outlined in the patent provide a novel approach to producing Actinium-225, which is essential for various medical applications.

Career Highlights

Eslam M Taha is affiliated with King Abdulaziz University, where he contributes to research and development in nuclear science. His work at the university has allowed him to explore innovative solutions in the production of radioactive isotopes.

Collaborations

Eslam has collaborated with esteemed colleagues such as Abdulsalam M Alhawsawi and Essam Banoqitah. These collaborations have further enhanced his research and development efforts in the field.

Conclusion

Eslam M Taha's contributions to the production of Actinium-225 highlight his innovative spirit and dedication to advancing nuclear science. His work not only showcases his expertise but also has the potential to impact medical treatments significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…